Title: Antipsychotic Medication Use in Children and Adolescents: A Resource Guide and Workbook
1Antipsychotic Medication Use in Children
andAdolescents A Resource Guide and Workbook
- Jeffery Thompson, MD, MPH
- Washington State Medicaid
- Chief Medical Officer
2How States Worked Together on this Project The
search for truth or something close.
- MMDLN invited a small number of States to discuss
AP medication management and whether comparing
systems and policies was possible between June of
2007 and August of 2009 - A series of informal discussions which generated
the Project Plan - A shared discussion among a subset of State
participants to develop a standardized Data
Dictionary - An informal data sharing agreement between 16
States to pull and share utilization and
demographic data - A survey of State programs and practices to
categorize polices, statutes, and utilization
controls related to mental health medications - A process to share State practices based on a
systematic process (best, promising, emerging,
and unknown) - A publication committee to write a Resource Guide
- Close connections with AHRQ, NASMD and NASMHD
3What were project challenges? The search for
truth or something close.
- Distributed Model
- Some issues arises (political, budget or other)
that has a common theme across states - Consensus building defines the project plan
- Common data dictionary and data pull at each
state - Discussions and surveys are used to ensure
validity - Data is aggregated
- The beginning
- Centralized Model
- Research idea responding to an RFP
- Null hypothesis and project plan in an RO1
- Data is centralized and analyzed (typically line
level) - Some mechanism is used to validate data
- Report or publication comes out
- The end
4What were project challenges? The search for
truth or something close.
- Centralized Model
- Pros
- The project has a narrow focus
- Definitions setting is not egalitarian
- Line level data allows for validity checks
- Cons
- Data and trends may be confounded scalar changes
and unknowns - The research question may not address the
community need
- Distributed Model
- Cons
- The project can morph
- Definitions is set by committee
- Aggregate data relies on state analyst
understanding - Pros
- Each state knows their community and structures
to address trend issues - States gain a unique understanding through the
process
5What were project challenges? Both models are
needed and need coordination!
- Centralized Model
- Can define the confounders and influencing issues
- Can test the intended and unintended consequences
- Can assist in merging costs and outcomes
- Distributed Model
- Defines the problem(s)
- Each state may have differing issues
- Integrates research into business/program model
- Sets the next step agenda for research
6What were the key findings in 16 States CY
2004-2007 Data?
- Growth trends in Antipsychotic (AP) medication
varied widely (48 percent decrease to a 39
percent increase) among the 16 States - More children in foster care (12.4 percent) were
prescribed AP medications than non-foster care
children (1.7 percent) - Just over 11 percent of children using AP
medications were prescribed four or more during a
calendar year (non-concurrent) - Over one-third of children (36 percent) had a
greater than 20-day gap in AP medication - 16 States, generated 26 best, promising and
emerging quality practices to assist states in
improving quality and reducing variation
7How can we measure issues? Red flags can assist
in Measures of Program Performance
- The project identified a common set of quality
concerns (red flags) to raise safety concerns - Children less than 5 years of age receiving AP
medications - Children and adolescents being prescribed three
or more mental health medications in a calendar
year - Children and adolescents being prescribed two or
more AP medications in a calendar year - Doses of antipsychotic medications exceeding
recommended range - Gaps in therapy that exceed 20 days
- States can use these red flags to highlight
variation in performance and trends as well as
review the best, promising, and emerging
practices to work with the prescribing community
to improve quality.
8How is Washington State using project data?
Executive Summary CY 2007
- Total users 4,978 (1.4) of enrolled kids used
an AAP - Growth trends AAP users grew 25 and unit costs
grew 38 comparing 2004 to 2007 - AAP use in the very young 187 AAPs users are
less than 5 years old - High dose 499 (10) of users are prescribed
high doses of AAPs - Multiple AAP use 896 (19) of users had two or
more AAP prescriptions - Multiple Mental Health Drug use 621 (2.3) of
kids are prescribed 5 or more mental health drugs - Adherence 1588 (39) had a gap in AAP use of
greater than 20 days. - Provider types AAP were prescribed by
Psychiatrists (45), PCP (34) and ARNP (21)
9How is Washington State using project data? CY
2004 2007 Trends
-
- A look at the trend data WA State found
-
-
- Next Steps Provider groups are reviewing chart
data and reasons for trends
PCP ARNP PSYCHIATRIST
gt 2 AAPs 13 24 63
gt 5 MHD 19 31 50
gt 20 day Gap 34 21 46
gt 2 MHD Prescribers 53 20 27
Comparing 2004-2007, these quality indicators appear to be improving for PCP and Psychiatrists and decreasing in ARNPs Comparing 2004-2007, these quality indicators appear to be improving for PCP and Psychiatrists and decreasing in ARNPs Comparing 2004-2007, these quality indicators appear to be improving for PCP and Psychiatrists and decreasing in ARNPs Comparing 2004-2007, these quality indicators appear to be improving for PCP and Psychiatrists and decreasing in ARNPs
10How is Washington State using project data? CY
2004 Regional Variation in Clients using 4 or
More Mental Health Drugs by County
Showing the regional variations engaged the
provider community in solutions and that quality
issues are present.
11How is Washington State using project data?
Because of variation a statewide call line was
setup.
- PAL is a Call in Line for mental health
questions by a Ped Psychiatrist - The UW will be doing a program review
Data Drives Programs, Statutes, Funding and
Quality
12Summary This Project will Assist States in
Ensuring Mental Health Drugs are Given the right
care at the right time for the right reason
Questions?